[Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis].
We compared the number of new gadolinium-enhancing (Gd+) and T2-weighted (T2W) lesions on 6-monthly MRI scans before and after initiating weekly intramuscular injections of interferon beta-1a (Avonex) 30 mcg. The mean number of new focal Gd+ lesions detected during the 6 monthly on-treatment scanning sessions was 58 per cent less per MRI scan and 62.5 per cent less per patient than during the 6 monthly pre-treatment scanning sessions (p = 0.016, Wilcoxon signed rank test). The results are similar for new focal Gd+ and T2W lesions. The reduction in disease activity detected by monthly Gd+ enhanced MRI scans after initiating weekly intramuscular interferon beta-1a 30 mcg is consistent with benefits observed with thrice weekly subcutaneous interferon beta-1a 10 and 30 mcg and alternate day subcutaneous interferon beta-1b 8.0 MIU.